APSARD

Review the misperceptions patients and clinicians may have about ADHD diagnosis and treatment.

Experts discuss the complex relationship between ADHD treatment and substance use disorder.

Barry Herman, MD, shares insights on real-world data of online ADHD assessment tool and telepsychiatry.

Clinicians explore the complex relationship between ADHD medication and pregnancy, emphasizing individualized risk assessments for optimal maternal and child health.

A groundbreaking online ADHD assessment shows 78% agreement with clinician evaluations, enhancing access to mental health care for adults.

Allison Baker, MD, shared insights on supporting women before, during, and after pregnancy at the APSARD conference.

Explore key insights on ADHD treatment barriers and the long-term outcomes for adolescents diagnosed with the disorder.

Benjamin E. Yerys, PhD, shares clinical insights on the impact of the comorbidity at the APSARD Conference.

New research reveals midlife ADHD patients exhibit early Alzheimer disease biomarkers.

Poster discusses evidence-based strategies for managing adult ADHD, including medication guidelines and considerations for comorbid conditions.

Poster presented at the APSARD Annual Conference demonstrates the importance of genetic testing in ADHD.

Centanafadine demonstrates promising effects on ADHD symptoms, enhancing key neurotransmitters without increasing psychomotor activity, according to poster data.

A look at upcoming presentations at APSARD 2026, January 15-18.

Check out these APSARD 2024 updates from Greg Mattingly, MD, president of the American Professional Society for ADHD and Related Disorders.

This APSARD 2024 conference poster finds that individuals with ADHD have distinct motivations and patterns of substance use.

The results were shared in a poster presentation at the 2024 APSARD Annual Meeting.

APSARD tackles the first US adult ADHD treatment guidelines.

Ann Childress, MD, the current president of APSARD, invites you to attend this year's conference!

In an exclusive interview, APSARD President Elect Greg Mattingly, MD, tells Psychiatric Times readers what they can expect at this year's meeting.

How do children with ADHD respond differently to reward and punishment, and how can we help them improve their executive functions?

What are the connections between ADHD, infectious diseases, and COVID-19?

How are minority children with ADHD affected by diagnostic, treatment, and educational inequities—and what can we do about it?

How does an ADHD diagnosis affect the college experience? Recent research allows the students to weigh in.

Is ADHD underdiagnosed or overdiagnosed? One doctor emphatically says the former.

You cannot touch mental health impairments, so how best can we measure them? Adaptive testing may be the answer.

College students who identify as a sexual and gender minority who also have ADHD may be at higher risk of functional impairments, substance use, and psychiatric comorbidities.

Helicopter parenting in teens with ADHD: What are the types and how do they affect children?

Ann Childress, MD, shares insights into ADHD in very young children at the 2022 APSARD Conference.